Hepatic Benefits Potentially reduces the incidence of metabolic liver diseases
The role of GSH in the mechanisms of apoptosis, necroptosis, ferroptosis, and autophagy is considered
This approach helps ensure that therapy is both safe and sustainable
The ability of eNOS produced NO to prevent platelet adhesion and aggregation reduces the propensity for the development of abnormal fibrin clots (thrombi) and, therefore, will contribute to a reduced potential for the development of atherosclerosis
Patients are frequently counselled on injection technique, on managing gastrointestinal side effects, and on the importance of dose titration
Many people assume their symptoms are just stress, aging, or burnout, when low B12 may be part of the picture